Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.

Brain M, Anderson M, Parkes S, Fowler P.

Crit Care Resusc. 2012 Dec;14(4):274-82.

PMID:
23230876
2.

Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.

Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.

BMC Nephrol. 2013 Oct 25;14:232. doi: 10.1186/1471-2369-14-232.

3.

Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.

Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, Genestal M, Durand D.

Nephrol Dial Transplant. 2004 Jan;19(1):171-8.

4.

Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.

Brain M, Parkes S, Fowler P, Robertson I, Brown A.

Crit Care Resusc. 2011 Jun;13(2):72-81.

PMID:
21627574
5.

A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.

Davies H, Morgan D, Leslie G.

Aust Crit Care. 2008 Aug;21(3):154-65. doi: 10.1016/j.aucc.2008.04.002. Epub 2008 Jul 16.

PMID:
18635373
6.

Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.

Swartz R, Pasko D, O'Toole J, Starmann B.

Clin Nephrol. 2004 Feb;61(2):134-43.

PMID:
14989634
7.

Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin.

Balik M, Zakharchenko M, Leden P, Otahal M, Hruby J, Polak F, Rusinova K, Stach Z, Tokarik M, Vavrova J, Jabor A, Oudemans-van Straaten HM.

J Crit Care. 2013 Feb;28(1):87-95. doi: 10.1016/j.jcrc.2012.06.003. Epub 2012 Aug 27.

PMID:
22951019
8.

A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.

Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R.

Crit Care Med. 2015 Aug;43(8):1622-9. doi: 10.1097/CCM.0000000000001004.

PMID:
25853591
9.
11.

Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients.

Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G.

Nephrol Dial Transplant. 2011 Dec;26(12):3882-8. doi: 10.1093/ndt/gfr106. Epub 2011 Mar 8.

12.

Regional citrate anticoagulation in continuous venovenous hemodiafiltration.

Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT.

Am J Kidney Dis. 2000 May;35(5):802-11.

PMID:
10793012
13.

Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.

Nagarik AP, Soni SS, Adikey GK, Raman A.

Saudi J Kidney Dis Transpl. 2010 May;21(3):478-83.

14.

Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial.

Brain MJ, Roodenburg OS, Adams N, McCracken P, Hockings L, Musgrave S, Butt W, Scheinkestel C.

Crit Care Resusc. 2014 Jun;16(2):131-7.

PMID:
24888284
15.

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.

Mariat C, Venet C, Jehl F, Mwewa S, Lazarevic V, Diconne E, Fonsale N, Carricajo A, Guyomarc'h S, Vermesch R, Aubert G, Bidault R, Bertrand JC, Zeni F.

Crit Care. 2006 Feb;10(1):R26.

16.

Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.

Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS.

Am J Kidney Dis. 1996 Apr;27(4):519-24.

PMID:
8678062
17.

A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).

Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR.

Clin Nephrol. 2003 Feb;59(2):106-14.

PMID:
12608553
19.

Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.

Palsson R, Laliberte KA, Niles JL.

Clin Nephrol. 2006 Jan;65(1):34-42.

PMID:
16429840
20.

Citrate clearance in children receiving continuous venovenous renal replacement therapy.

Chadha V, Garg U, Warady BA, Alon US.

Pediatr Nephrol. 2002 Oct;17(10):819-24. Epub 2002 Sep 7.

PMID:
12376810
Items per page

Supplemental Content

Write to the Help Desk